Objective
Cancer cachexia is a life-threatening syndrome characterized by severe body weight loss, due to depletion of adipose tissue and skeletal muscle, and affects up to 80% of patients with advanced cancers. The rapid loss of muscle mass is the main cause of function impairment, fatigue and respiratory complications, leading to death in 20-48% of cases. To date, no effective treatment is available. By using Ingenuity Pathways Analysis software, I have analyzed the cancer cachexia-specific genes, found previously by others, and discovered a specific signaling pathway altered in muscles of cachectic rats. By over-expressing and repressing genes of this pathway in in vitro (adenoviral infection of myotubes) and in vivo (muscle electroporation of plasmids in mice) approaches, I will dissect the role of this signaling cascade during cachexia. Since agonists and antagonists for this pathway are already available, they will be also tested for their possible protective effects against cancer cachexia. Physical activity extends life span of cancer patients and correlates with lower incidence of many cancers but its modes of action are still unclear. The concept that muscle is an endocrine organ able to release molecules (myokines) is quiet new and opens exciting fields to explore. Interestingly, the unique resistance of muscle to cancer and metastasis makes reasonable that anti-cancer myokines may exist. Their secretion especially during physical activity could explain why exercise protects from cancers and retards its progression. So, I propose to search for novel anti-cancer molecules from exercised muscles by taking advantage of adenoviral infection of myotubes to express molecules able to mimic some of the effects of (strength or endurance) exercise. The isolation of anti-cancer myokines may greatly help cancer patients, especially those that cannot exercise, and may clarify which type of exercise (i.e. strength and/or endurance) could be more beneficial for cancer patients.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
- natural sciences computer and information sciences software
- medical and health sciences clinical medicine oncology
- natural sciences chemical sciences electrochemistry bioelectrochemistry electroporation
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
FP7-PEOPLE-2010-RG
See other projects for this call
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
20156 Milano
Italy
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.